From: Ontology-based venous thromboembolism risk assessment model developing from medical records
 | VTE | non-VTE | P value | Total |
---|---|---|---|---|
N | 224 | 2882 | – | 3106 |
Gender (Male) | 119 (53.13%) | 1587 (55.07%) | >  0.05 | 1673 |
Age (Year) | 55.81 ± 16.45 | 52.75 ± 16.24 | <  0.05 | 52.97 ± 16.28 |
BMI (Kg/m2) | 23.99 ± 4.13 | 23.47 ± 4.27 | >  0.05 | 23.51 ± 4.26 |
Hospital stay (Day) | 22 (14, 35) | 11 (6, 18) | <  0.05 | 12 (6, 19) |
Padua Score | 5.88 ± 2.46 | 2.89 ± 2.45 | <  0.05 | 3.10 ± 2.57 |
High Risk (Padua model) | 194 (86.61%) | 1078 (37.40%) | <  0.05 | 1272 |
Active malignant cancer/chemotherapy | 70 (31.25%) | 807 (28.00%) | >  0.05 | 877 |
Previous VTE | 34 (15.28%) | 17 (0.59%) | <  0.05 | 51 |
Reduced mobility | 158 (70.54%) | 1030 (35.74%) | <  0.05 | 1188 |
Thrombophilic condition | 25 (15.63%) | 53 (1.84%) | <  0.05 | 88 |
Recent trauma/surgery | 14 (6.25%) | 87 (3.02%) | >  0.05 | 101 |
Age > =70 | 45 (20.09%) | 418 (14.50%) | <  0.05 | 463 |
Heart/respiratory failure | 65 (29.12%) | 112 (3.89%) | <  0.05 | 177 |
Acute myocardial infarction/ischemic stroke | 8 (3.57%) | 44 (1.53%) | >  0.05 | 52 |
Acute Infection/rheumatologic disorder | 131 (58.48%) | 710 (24.64%) | <  0.05 | 841 |
BMI > =30 kg/m2 | 13 (5.80%) | 165 (5.73%) | >  0.05 | 178 |
Ongoing glucocorticoid treatment | 136 (60.71%) | 972 (33.73%) | <  0.05 | 1108 |